DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
eBay
EBAY
Collegium Pharmaceutical
COLL
Dorian LPG
LPG
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 19.680
- -0.690-3.39%
Close Mar 28 16:00 ET
- 19.680
- 0.0000.00%
Post 16:20 ET
1.75BMarket Cap-4.82P/E (TTM)
20.478High19.444Low1.14MVolume20.430Open20.370Pre Close22.56MTurnover1.51%Turnover RatioLossP/E (Static)88.74MShares25.29052wk High29.55P/B1.49BFloat Cap5.12052wk Low--Dividend TTM75.50MShs Float37.040Historical High--Div YieldTTM5.08%Amplitude0.000Historical Low19.813Avg Price1Lot Size
About Travere Therapeutic Company
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Company Profile
SymbolTVTX
Company NameTravere Therapeutic
Listing DateJan 10, 2014
Founded2008
CEODr. Eric M. Dube, PhD
MarketNASDAQ
Employees385
Fiscal Year Ends12-31
Address3611 Valley Centre Drive,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-888-969-7879
Websitehttp://www.travere.com
Company Executives
- Name
- Position
- Salary
- Dr. Eric M. Dube, PhD
- Director, President and Chief Executive Officer
- 7.57M
- Sandra Calvin
- Senior Vice President and Chief Accounting Officer
- --
- Peter Heerma
- Chief Commercial Officer
- 2.00M
- Christopher Cline
- Chief Financial Officer
- 1.97M
- Dr. Jula Inrig
- Chief Medical Officer
- --
- Elizabeth E. Reed
- Senior Vice President, General Counsel and Corporate Secretary
- 2.02M
- William E. Rote
- Senior Vice President, Research and Development
- 2.05M
- Gary A. Lyons
- Chairman of the Board
- 392.98K
- Sandra E. Poole
- Independent Director
- 369.86K
- Ruth WilliaBrinkley
- Independent Director
- 365.48K
- Timothy P. Coughlin
- Independent Director
- 385.48K
- Ron Squarer
- Independent Director
- 367.98K
- John A. Orwin, M.B.A.
- Independent Director
- 372.98K
- Jeffrey A. Meckler
- Independent Director
- 379.98K
- Dr. Suzanne L. Bruhn, PhD
- Independent Director
- 372.36K
- Dr. Roy D. Baynes, M.D.,PhD
- Independent Director
- 376.73K